Parkman Healthcare Partners LLC
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1777015
STAMFORD, CT
Position in SUPN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,396,854
+$940,927 QoQ
Shares Held
85,062
-28.8% QoQ
Ownership
0.147%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
12 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Parkman Healthcare Partners LLC holds $90,125,176 across 8 Drug Manufacturers - Specialty & Generic names. SUPN ranks #7 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANIP |
Ani Pharmaceuticals Inc
|
280,575 | $21,576,217 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,708,099 | $16,261,102 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
99,069 | $13,051,350 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
259,184 | $12,479,709 | |
| 5 | XERS |
Xeris Biopharma Holdings, Inc.
|
1,721,264 | $9,983,331 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
621,458 | $8,638,266 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
85,062 | $4,396,854 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
300,752 | $3,738,347 |
All Filings in SUPN
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,396,854 | 85,062 | Shares | Sole | 2026-05-15 | |
| 2023-12-31 | $3,455,927 | 119,417 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,809,402 | 138,172 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,716,780 | 190,179 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $4,777,939 | 131,878 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,385,297 | 94,906 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,036,649 | 89,709 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,563,989 | 88,658 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,521,393 | 108,954 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,053,460 | 104,714 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,678,068 | 100,415 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,091,777 | 100,415 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||